UroAlert - GU Oncology Daily

July 07, 2026

Videos

Peer-to-Peer Clinical Conversations

Treatment Burden in Older Adults with Non-Muscle Invasive Bladder Cancer - Tullika Garg

Tullika Garg

Tullika Garg discusses treatment burden and a goal elicitation communication tool for older adults with non-muscle invasive bladder cancer.

PARP Inhibitors in Prostate Cancer: A Decade of Development and the Combination vs Monotherapy Debate for HRR-Mutated Disease - Neeraj Agarwal

Neeraj Agarwal

Pedro Barata interviews Neeraj Agarwal about PARP inhibitors in prostate cancer following an educational session.

Beyond the Abstracts

Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter - Beyond the Abstract

Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study - Beyond the Abstract

Conference Coverage

ASCO 2026: Phase 2 Multicenter Trial of Chemoimmunotherapy for Patients with Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)

ASCO 2026: Interim Analysis Results from Duravelo-2: Zelenectide Pevedotin in Patients with Previously Treated la/mUC

AUA 2026: Debate: Trimodality Therapy for Muscle-invasive Bladder Cancer: Radiation, Responsibility – Who Manages the Fallout, and How?

AUA 2026: Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ

EAU 2026: International Delphi Consensus on UTUC Management: The IMPACT UTUC Project

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.

Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

Renal Cancer

Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus.

Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC).

Prostate Cancer

Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans.

Comparison of MRI-guided in-bore and fusion biopsy for small PI-RADS 4 prostate lesions.

Racial Differences in Psychosocial Outcomes Among Prostate Cancer Survivors: Insights From the All of Us Research Program.

Artificial intelligence-enabled MRI surveillance of prostate cancer: integrating PRECISE v2, PI-QUAL, and longitudinal biomarkers-a narrative review.

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC